Procter & Gamble (PG) is back in focus after analysts turned more cautious ahead of its July 29 earnings report, as they expect earnings per share to decline even as sales are projected to grow.

Recent caution around Procter & Gamble’s earnings outlook has weighed on sentiment, with the share price down 2.6% over the past month and the 1 year total shareholder return declining 4.7%, suggesting momentum has faded despite a positive year to date share price return of 3.7%.

If this earnings setup has you rethinking where growth and income might come from next, it could be a good time to scan 17 top founder-led companies

Procter & Gamble’s share price has slipped while analyst value estimates still sit higher. This leaves a clear gap between where the stock trades and where many models place fair value. Is that discount justified once you run the numbers?

Most Popular Narrative: 21.4% Overvalued

The most followed narrative on Procter & Gamble pegs fair value at $121.06, below the last close of $146.97, which sets up a clear valuation tension investors are watching.

Procter & Gamble, despite being within a very competitive industry, still has some competitive advantages shown in its higher operating margin above the ~20% mark and the Morning Star Wide Moat. Also, the fact that the ROIC is double the Cost of Capital means its capital allocation is being well managed. Its solid Moodys Debt Rating along with the Low Uncertainty Morningstar rating maintains the company as a stable and reliable investment if the opportunity arises.

The narrative focuses on strong margins, disciplined capital allocation and a wide moat, then tempers that with modest growth and a discount rate that keeps the valuation framework tight. Want to see how those pieces fit together into that $121.06 figure and what it implies for Procter & Gamble beyond the next quarter?

Result: Fair Value of $121.06 (OVERVALUED)

However, Procter & Gamble’s 1 year total return decline of 4.7% and analyst expectation for earnings per share to fall could challenge confidence in that 121.06 dollar fair value.

Another View on Procter & Gamble’s Value

While one widely cited narrative values Procter & Gamble at $121.06 and considers the current $146.97 price as overvalued, the Simply Wall St DCF model offers a different perspective, with an estimated future cash flow value of $191.89. This implies the stock trades at a 23.4% discount. Which story do you trust when cash flows and narrative move in different directions?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Procter & Gamble for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 38 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With Procter & Gamble’s mixed signals on valuation, earnings expectations and recent returns, this is a moment to move quickly, review the full data set, and weigh both the concerns and potential upsides highlighted in the community analysis, including the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Procter & Gamble?

If Procter & Gamble’s mixed signals have you thinking more broadly about where to put fresh capital, it is worth widening the lens while sentiment is still recalibrating.

• Target higher potential returns by scanning 21 elite penny stocks with strong financials that pair smaller market caps with stronger financial profiles than many investors expect.
• Zero in on value opportunities using the 38 high quality undervalued stocks to spot companies with solid fundamentals that currently trade below their estimated worth.
• Prioritize resilience and sleep better at night by reviewing the 79 resilient stocks with low risk scores that screens for companies with comparatively stronger risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.